As healthcare professionals, it is crucial to deepen our understanding of neurodegenerative disorders. One such condition that requires our attention is Parkinson's disease, a progressive disorder of the nervous system that affects movement. This article aims to provide a comprehensive overview of Parkinson's disease.
Parkinson's disease is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, resulting in a deficiency of the neurotransmitter dopamine. This deficiency is primarily responsible for the motor symptoms associated with the disease. The exact cause of this neuronal death is still unknown, but it is believed to involve both genetic and environmental factors.
The cardinal symptoms of Parkinson's disease include bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are also common and can significantly impact the quality of life of these patients.
Diagnosis of Parkinson's disease is primarily clinical, based on the presence of characteristic motor symptoms and the response to dopaminergic therapy. Neuroimaging studies, such as DaTscan, can support the diagnosis, but are not typically necessary.
While there is no cure for Parkinson's disease, several treatment options can help manage symptoms. These include pharmacological treatments, such as levodopa and dopamine agonists, and non-pharmacological interventions, such as physical therapy. In advanced cases, deep brain stimulation may be considered.
As healthcare professionals, our role in managing Parkinson's disease is not just to treat motor symptoms, but also to address the non-motor symptoms and improve the overall quality of life of our patients. By deepening our understanding of this complex disorder, we can provide better care for our patients and contribute to the ongoing research in this field.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation